MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0011220
Nilrise Pharmaceuticals Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.92 Cr
▲ 6% YoY
Net profit · FY 2025
₹18.25 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹43.75 Lakh
EBITDA margin 4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹2.16 Cr
Satisfied ₹10 Lakh
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
About Nilrise Pharmaceuticals Private Limited
Data last updated:
Nilrise Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51101GJ2014PTC078226. Its GSTIN is 24AAECN5618G1ZL (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Jitendrabhai Lalajibhai Lakhani (Managing Director) and Hiral Jitendrabhai Lakhani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 706 Signature II Sarkhej Sanand Highway Sarkhej Ahmedabad, Gujarat, India – 382210.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.92 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹18.25 Lakh (net margin 1.7%) and EBITDA of ₹43.75 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 14% over five years.
The company is associated with 1 brand: Nilrise Pharma. As per MCA filings, the company has open charges of ₹2.16 Cr and satisfied charges of ₹10 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Nilrise Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0011220). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nilrisepharma.com.
Company details
CIN U51101GJ2014PTC078226
Registration Number 078226
Incorporation Date 09 January 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0011220
Key People
Jitendrabhai Lalajibhai Lakhani Managing Director Hiral Jitendrabhai Lakhani Director Hardikkumar Kalubhai Vaghasiya Director Recognitions & Rankings of Nilrise Pharmaceuticals
Contact details
Nilrise Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is nilrisepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address706 Signature II Sarkhej Sanand Highway Sarkhej Ahmedabad, Gujarat, India – 382210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nilrise Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Nilrise Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nilrise Pharmaceuticals operates one associated brand: Nilrise Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| PCD Pharma franchise and pharmaceutical distribution services in India. | nilrisepharma.com |
Business activity
The main business activity of Nilrise Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nilrise Pharmaceuticals Private Limited, buy the company report.
Financials of Nilrise Pharmaceuticals Private Limited
FY 2025 filings availableNilrise Pharmaceuticals Private Limited reported revenue of ₹10.92 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹10.92 Cr ▲ 6%
Net profit · FY 2025
₹18.25 Lakh margin 1.7%
EBITDA · FY 2025
₹43.75 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 3%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 19%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 6% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nilrise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nilrise Pharmaceuticals Private Limited
Nilrise Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendrabhai Lalajibhai Lakhani Also directs: Healthiza Lifescience Private Limited, Crinova Healthcare Private Limited, Irenic Capitals Private Limited and 1 more | Managing Director | 09 Jan 2014 | 12 Years 9 Months | Current |
| Hiral Jitendrabhai Lakhani | Director | 09 Jan 2014 | 12 Years 9 Months | Current |
| Hardikkumar Kalubhai Vaghasiya | Director | 09 Jan 2014 | 12 Years 9 Months | Current |
Auditor
Nilrise Pharmaceuticals Private Limited is audited by H.D.NAKARANI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.D.NAKARANI & ASSOCIATES | FY 2023 | 140020W |
Shareholding
The shareholding of Nilrise Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nilrise Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.16 Cr
Satisfied charges
₹10 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jun 2022 | 100618916 | Others | ₹1.61 Cr | Open | |
| 15 Jul 2021 | 100466025 | Axis Bank Limited | ₹6.99 Lakh | Open | |
| 21 Aug 2019 | 100286801 | Axis Bank Limited | ₹48.5 Lakh | Open | |
| 13 Jun 2018 | 100187835 | Yes Bank Limited | ₹10 Lakh | Satisfied |
To see the full charge records of Nilrise Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Nilrise Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by FDC Limited | Disposed |
To see the full case history of Nilrise Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nilrise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nilrise Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
Nilrise Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECN5618G1ZL | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nilrise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Nilrise Pharmaceuticals Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Hardikkumar Kalubhai Vaghasiya was appointed as Director on 09 Jan 2014.
AGM
Nilrise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nilrise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others of Rs. 161.00 Lakh registered on 24 Jun 2022 with Charge ID 100618916 was modified on 16 Sep 2022.
Charges
A charge with Others amounted to Rs. 161.00 Lakh with Charge ID 100618916 was registered on 24 Jun 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.99 Lakh with Charge ID 100466025 was registered on 15 Jul 2021.
Charges
A charge registered on 13 Jun 2018 via Charge ID 100187835 with Yes Bank Limited was fully satisfied on 20 Sep 2019.
Charges
A charge with Axis Bank Limited amounted to Rs. 48.50 Lakh with Charge ID 100286801 was registered on 21 Aug 2019.
Charges
A charge with Yes Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 100187835 was registered on 13 Jun 2018.
Appointed
Hardikkumar Kalubhai Vaghasiya was appointed as Director.
Appointed
Hiral Jitendrabhai Lakhani was appointed as Director.
Appointed
Jitendrabhai Lalajibhai Lakhani was appointed as Managing Director.
Incorporation
09 Jan 2014
Nilrise Pharmaceuticals Private Limited was registered on 09 Jan 2014 with Roc Ahmedabad & aged 12 years 9 months as per MCA records.
Frequently asked questions
Nilrise Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2014 (12+ years old) and is registered under CIN U51101GJ2014PTC078226.
Nilrise Pharmaceuticals has 3 current directors:
- Jitendrabhai Lalajibhai Lakhani - Managing Director
- Hiral Jitendrabhai Lakhani - Director
- Hardikkumar Kalubhai Vaghasiya - Director
The latest financial statements of Nilrise Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nilrise Pharmaceuticals is 24AAECN5618G1ZL, registered in Gujarat.
The CIN (Corporate Identification Number) of Nilrise Pharmaceuticals is U51101GJ2014PTC078226. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nilrise Pharmaceuticals has 1 court case on record: 1 filed against it.
Nilrise Pharmaceuticals was incorporated on 09 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hardikkumar Kalubhai Vaghasiya was appointed as Director on 09 Jan 2014. Hiral Jitendrabhai Lakhani was appointed as Director on 09 Jan 2014. Jitendrabhai Lalajibhai Lakhani was appointed as Managing Director on 09 Jan 2014.
Yes, Nilrise Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0011220).
Nilrise Pharmaceuticals can be reached through the website nilrisepharma.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages